Case Series
of fever, productive cough associated with shortness of breath, orthopnea, paroxysmal nocturnal dyspnea. He denied any history of chest pain, syncope, or palpitations. Medical and surgical history was insignificant. On physical examination, the patient looked unwell. He was febrile (38.5°C), with a pulse rate of 138 beats/min, blood pressure of 114/86 mmHg, and respiratory rate of 28/min. Chest examination revealed left lower lobe crackles and dullness. Electrocardiogram (EKG) showed sinus tachycardia [ Figure 1 ]. Chest X-ray (CXR) [ Figure 2a ] showed left lower lobe consolidation and bilateral pleural effusion, which was more prominent on the left. Computed tomography (CT) scan of the chest [ Figure 2b ] revealed bilateral airspace disease more on the left lower lobe, bilateral pleural effusions more on the left side with pleural thickening, and minimal pericardial effusion.
Echocardiogram (ECHO) [ Figure 3 ] revealed a normal left ventricular wall thickness and moderate global hypokinesis of left ventricle. EF was 35%-45%. Liver function test (LFT) revealed albumin 33 g/dl, total bilirubin 31.3 mg/dl, alkaline phosphate 249 mg/dl, and alanine transaminase (ALT) 21 U/L. Erythrocyte sedimentation rate (ESR) 33 mm/h, hemoglobin (Hb)-152 g/dl, and Pro-BNP 530 pg/mL. Sputum for acid-fast bacilli (AFB) was negative 3 times. Abdominal ultrasound showed moderate hepatomegaly and splenomegaly with no ascites. Pleural fluid analysis revealed exudative effusion, total protein 49, lactate dehydrogenase 238, white blood cell (WBC) -4/mm 3 , lymphocytes 86%. QuantiFERON (QTF) was positive. HIV nonreactive. Bronchoscopy was done. Bronchoalveolar lavage (BAL) was negative for AFB, but polymerase chain reaction (PCR) was positive for Mycobacterium tuberculosis, transbronchial lung biopsy revealed multiple interstitial and subpleural noncaseating, nonnecrotizing granuloma.
The patient was diagnosed as disseminated TB involving lungs, pleura, liver, and spleen. Patient was started on the standard four anti-TB drugs. Follow-up BAL culture was positive for M. tuberculosis and pansensitive organism. ECHO was repeated after 2 months and revealed normal EF (EF > 55).
Case 2
A 21-year-old man previously healthy presented to the emergency department with a history of recurrent fever, progressive dyspnea, and cough with yellowish sputum for 2 months. He received several courses of antibiotics without improvement. The patient does not have chest pain or hemoptysis but reported loss of weight and appetite. He has no other medical problems, denied any contact with TB cases. On examination, his vital signs were as following: Temperature: 36.6°C, respiratory rate: 25 breaths/min, heart rate: 112 beats/min, and blood pressure: 133/82 mmHg. On examination, the patient generally looked stable but required oxygen of 4-5 L to keep oxygen above 90% and bronchial breathing was noted over the right upper lobe of the chest. Initial laboratory test revealed WBC: 8.2/mm 3 , Hb: 109 g/dl, 
Case 3
A 34-year-old female admitted to our hospital with main complaints of fever, cough, lower abdominal pain, and weight loss for a few months. She was seen in another hospital and was diagnosed as Crohn's disease and was started on prednisone, mesalamine, and azathioprine. On examination, the patient was looking unwell but conscious and oriented. 
dIscussIon
Although global incidence of TB is declining, TB remains one of the most prevalent infectious etiologies around the world. In 2014, worldwide, 9.6 million people were estimated to be infected and 1.5 million deaths occurred because of TB. [1] TB can affect any organ in the body, but it is generally believed that cardiac involvement is less common and TB myocarditis and cardiomyopathy are extremely rare. Only 0.14%-2% of TB patients have cardiac involvement, mainly pericardium. [2] [3] [4] The exact mechanism of TB myocarditis is not clear; however, three possible mechanisms are proposed from hematogenous seeding, direct infection from infected pericardium, or by retrograde lymphatic drainage from the tuberculous mediastinal lymph node. [3] [4] [5] 12, 13] Our three cases meet the definition of known clinical entity of a reversible acute left ventricular dysfunction (LVD) without any evidence of coronary artery obstruction but secondary to Mycobacterium myocarditis called takotsubo cardiomyopathy (TTC). [14] All the patients from the cases we are reporting were very young from 20 to 32 years old. This is similar to many reported cases where it affects young individuals. [2, 4, 5, 8, 12, 13, [15] [16] [17] However, it has also been reported in older patients. [7, 18] Most of the reported cases were among immunocompetent patients. [2, 4] In our cases, only one patient was on immunosuppressive agent for presumed Crohn's disease developed acute pulmonary TB and acute bowel perforation. We believe she has TB ileitis that was misdiagnosed as Crohn's disease. We believe her presentation of disseminated TB and cardiomyopathy was the result of using immunosuppressive therapy and due to the delay in the diagnosis of TB. Endomyocardial biopsy for TB myocarditis is neither sensitive nor diagnostic even in cases with confirmed TB. [13, 18] Isolated involvement of myocardium is reported in 25% while concomitant organ involvement is reported in 75% of cases, 56% pulmonary, 56% extrapulmonary, and 43% pericarditis. [3] Mortality rate in almost 30%. [3] All of our cases have concomitant disseminated TB (involvement of at least two organs). All of our cases were diagnosed as LVD based on clinical confirmation of TB and reversibility of cardiac function to normal post anti-TB therapy. No endomyocardial biopsy performed. We believe in the right clinical context and when the diagnosis of TB is confirmed, endocardial biopsy may not be necessary. If TB is suspected as a cause of myocarditis, appropriate investigations such as chest CT, sputum for AFB stain, and culture should be performed and TB-PCR, QTF, bronchoscopy and BAL, transbronchial or endoscopic ultrasound-guided biopsies should be requested before considering endocardial biopsy. [13, 19] Cardiac magnetic resonance imaging (MRI) may help in the diagnosis of TB myocarditis. Several case reports demonstrated cardiac MRI's value in the diagnosis of TB myocarditis and endocarditis. [20] [21] [22] [23] [24] TTC is a very serious disease and unfortunately if the diagnosis is missed or delayed, it can lead to fatal outcomes. [2, 4, 5, 7, 8, 10, 12, 17, 25] With increasing prevalence of TB, the possibility of potentially fatal myocardial TB must be considered. Two of our cases have short period of symptoms with a modest reduction of LVD while in the third case, the diagnosis was delayed for a few months, which may explain the severe LVD. None of our cases developed cardiac arrhythmias, and ECHO was requested to search for the cause of dyspnea and sinus tachycardia. Good response to antituberculosis therapy was reported in 68%. [3] The favorable outcome of LVD may be because the clinical presentations of our cases were highly suggestive of TB and diagnosis and initiation of treatment were rapid. Similar to our experiences, excellent outcome with complete reversibility of LVD has been reported with early commencement of anti-TB. [5, 13, 22, 23, 26] Paradoxical worsening post TB has been proposed as a possible cause of LVD in one case. [2] We could not confirm this in our cases as we do not have a baseline ECHO in all cases before the commencement of anti-TB.
conclusIon
The clinician should have a high index of suspicion of myocarditis in any patient with unexplained tachycardia or signs of left ventricular failure or any arrhythmia in a patient with suspected or confirmed TB. Furthermore, in the right context where the patient is at high risk for TB and presents with an unexplained arrhythmia or congestive heart failure, TB should be suspected as the underlying cause. Misdiagnosis or delay in the diagnosis of TB myocarditis has portentous outcome.
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